CADL logo
Candel Therapeutics, Inc.(CADL)
Last print unknown agoAbout this dataData status
$8.21▲0.02 (0.24%)Stale · unknown old

CADL R&D to Revenue

0.00%Fiscal year

Period ending:

CADL FY R&D/Revenue%
CADL FY R&D/Revenue18625.15%-1995.55%
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

CADL r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Candel Therapeutics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
0%
0%
0%
16,629.6%
12,142.4%
7,003.2%
5,285.6%

Compare r&d to revenue

All CADL financial metrics · CADL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.